Covid-19 pandemic has let us realize the actual situation of healthcare Industry. Many developed and developing countries across the globe are facing the challenges in terms of manufacturing medicines, creating a stout healthcare facility, producing medical equipment for treatment and trained healthcare professionals. During this period we saw the shortage of ventilators too that is very important in the treatment of Covid-19 patients. Some companies see the opportunity and are trying to build products around it. One such medical device companies has started working on a solution to take care of the facility acquired infection and manual monitoring via online portals through “remote access” to fight COVID-19 – Remote Ventilator.
ABM Respiratory Care, a Singapore based company is engaged in the development of airway solutions and ventilators. They have declared about their innovative ventilator that helps health professionals to program the device remotely and monitor the patient in real-time from anywhere in the world. The company has already applied for approvals with the Government and other regulatory bodies in Singapore and various other countries. But the important thing to know is will Remote Ventilator stays after the COVID-19?
BiWaze™ Ion is a product of ABM Respiratory Care. This product works in a unique way and there is no requirement of an IT team in the hospital or at home. This product is quite simple to operate and the steps are:
- Switch on the device (ventilator) and connect it to the nearest wi-fi or hotspot
- Login to the portal in order to manage the ventilators
The device works magically in just two simple steps. BiWaze™ ION has been in production for the last two and a half years The company already boasts of having functional devices which are appropriately tested for use and connectivity setups. They have also established supply chains and building inventories. The company is in the process of starting a full-fledged BiWaze™ Ion production line in just a few weeks.
With this current demand-supply crisis, many countries have realized the shortfalls and post COVID-19, countries would like to become self-reliant. Connectivity and Communication will be a key consideration post COVID19. Later in the healthcare industry, Home Treatment and Tele Consultation solutions for patients will witness increased demand. We also need to understand that there was a huge dependency on hospitals and in-person treatment. Now people will realize with this lockdown that had there been more usage of Tele-Consultation, it would have been easy for them to get treated right from their home.
Conventional ventilators are safer but these are not designed for skill shortage and mass usage scenarios. The connectivity ecosystem in the medical world is quite complex and extremely difficult to setup. Today, the world needs smarter ventilators that are based on new technologies and can work in a unique way enabling access to healthcare providers anywhere across the globe.
This company is presently focusing on Asia, keeping Singapore and India as their prime focus. They are working with regulatory agencies in these regions owing to insufficient time. They are aiming at catering to the rest of Asia, the Middle East and Africa with increased production. They are ready to collaborate in other regions so as to use their technology to save more lives.